natgillin/translations-raw huggingface dataset:
Why is MACI approved?
Zakaj je bilo zdravilo MACI odobreno?
Why is Mekinist approved?
Zakaj je bilo zdravilo Mekinist odobreno?
Why is Metacam approved?
Zakaj je bilo zdravilo Metacam odobreno?
Why is Nordimet approved?
Zakaj je bilo zdravilo Nordimet odobreno?
Why is NovoEight approved?
Zakaj je bilo zdravilo NovoEight odobreno?
Why is Nucala approved?
Zakaj je bilo zdravilo Nucala odobreno?
Why is Olysio approved?
Zakaj je bilo zdravilo Olysio odobreno?
Why is Oncaspar approved?
Zakaj je bilo zdravilo Oncaspar odobreno?
Why is Onivyde approved?
Zakaj je bilo zdravilo Onivyde odobreno?
Why is Opdivo approved?
Zakaj je bilo zdravilo Opdivo odobreno?
Why is Opsumit approved?
Zakaj je bilo zdravilo Opsumit odobreno?
Why is Orkambi approved?
Zakaj je bilo zdravilo Orkambi odobreno?
Why is Pandemic influenza vaccine H5N1 MedImmune approved?
Zakaj je bilo zdravilo cepivo proti pandemski gripi H5N1 MedImmune odobreno?
Why is Plegridy approved?
Zakaj je bilo zdravilo Plegridy odobreno?
Why is Porcilis PCV ID approved?
Za kaj se zdravilo Porcilis PCV ID uporablja?
Why is Praluent approved?
Zakaj je bilo zdravilo Praluent odobreno?
Why is Raplixa approved?
Zakaj je bilo zdravilo Raplixa odobreno?
Why is Ravicti approved?
Zakaj je bilo zdravilo Ravicti odobreno?
Why is Relvar Ellipta approved?
Zakaj je bilo zdravilo Relvar Ellipta odobreno?
Why is Remsima approved?
Zakaj je bilo zdravilo Remsima odobreno?
Why is Repatha approved?
Zakaj je bilo zdravilo Repatha odobreno?
Why is Revinty Ellipta approved?
Zakaj je bilo zdravilo Revinty Ellipta odobreno?
Why is RoActemra approved?
Zakaj je bilo zdravilo RoActemra odobreno?
Why is Sevelamer carbonate Zentiva approved?
Zakaj je bilo zdravilo Sevelamer carbonate Zentiva odobreno?
Why is SevoFlo approved?
Zakaj je bilo zdravilo SevoFlo odobreno?
Why is Sevohale approved?
Zakaj je bilo zdravilo Sevohale odobreno?
Why is Simponi approved?
Zakaj je bilo zdravilo Simponi odobreno?
Why is Sovaldi approved?
Zakaj je bilo zdravilo Sovaldi odobreno?
Why is Stayveer approved?
Zakaj je bilo zdravilo Stayveer odobreno?
Why is Strensiq approved?
Zakaj je bilo zdravilo Strensiq odobreno?
Why is Sylvant approved?
Zakaj je bilo zdravilo Sylvant odobreno?
Why is Tafinlar approved?
Zakaj je bilo zdravilo Tafinlar odobreno?
Why is Tagrisso approved?
Zakaj je bilo zdravilo Tagrisso odobreno?
Why is Translarna approved?
Zakaj je bilo zdravilo Translarna odobreno?
Why is Vantobra approved?
Zakaj je bilo zdravilo Vantobra odobreno?
Why is Viekirax approved?
Zakaj je bilo zdravilo Viekirax odobreno?
Why is Vitekta approved?
Zakaj je bilo zdravilo Vitekta odobreno?
Why is Voriconazole Hospira approved?
Zakaj je bilo zdravilo Voriconazole Hospira odobreno?
Why is Xigduo approved?
Zakaj je bilo zdravilo Xigduo odobreno?
Why is Xofigo approved?
Zakaj je bilo zdravilo Xofigo odobreno?
Why is Xtandi approved?
Zakaj je bilo zdravilo Xtandi odobreno?
Why is ZACTRAN approved?
Zakaj je bilo zdravilo ZACTRAN odobreno?
Why is Zerbaxa approved?
Zakaj je bilo zdravilo Zerbaxa odobreno?
Why is Zoledronic Acid Accord approved?
Zakaj je bilo zdravilo Zoledronic Acid Accord odobreno?
Why is Zydelig approved?
Zakaj je bilo zdravilo Zydelig odobreno?
Why is Zykadia approved?
Zakaj je bilo zdravilo Zykadia odobreno?
Why should I prime my pen before each dose?
Zakaj moram pred vsakim odmerjanjem pripraviti moj peresnik?
Why should I use a new needle for each injection?
Zakaj moram za vsako injiciranje uporabiti novo iglo?
Wide-brimmed hat: for head, neck, nose and ears.
Klobuk s širokim robom: za glavo, vrat, nos in ušesa.
Widening of blood vessels, low blood pressure when you stand up from sitting or lying down (postural hypotension)
razširjenje krvnih žil, nizek krvni tlak ob vstajanju s sedečega ali ležečega položaja (posturalna hipotenzija);
Widening of the pupil of the eye (mydriasis)
razširitev očesne zenice (midriaza)
widespread blood clotting and bleeding
razširjena koagulacija in krvavitev
Widespread inflammation of the lungs which may lead to scarring
obsežno vnetje pljuč, ki lahko povzroči brazgotinjenje
widespread skin rash
razširjen kožni izpuščaj
Widespread use of a 2-dose vaccination schedule in the United States and countries such as Finland and Sweden has led to a >99% reduction in the incidence of each of the 3 targeted diseases.
Razširjena uporaba cepljenja z 2 odmerkoma v ZDA in državah, kot sta Finska in Švedska, je vodila v > 99-odstotno zmanjšanje pojavnosti vsake od teh 3 bolezni.
Widespread use of a 2-dose vaccination schedule in the United States and countries such as Finland and Sweden has led to a >99% reduction in the incidence of each of the 3 targeted diseases.
Razširjena uporaba cepljenja z 2 odmerkoma v ZDA in državah, kot sta Finska in Švedska, je vodila v > 99-odstotno zmanjšanje pojavnosti vsake od teh treh bolezni.
Wilcoxon Signed Rank
Wilcoxonov predznačen rang
Wilcoxon-Mann-Whitney Test
preizkus Wilcoxon-Mann- Whitney
Wild-type RAS (n = 69)
Divji tip RAS (n = 69)
Wild-type RAS population
Populacija z divjim tipom RAS
will be assessed for germline genetic variability in angiogenic factors,
na podlagi genetske raznovrstnosti zarodnih linij, angiogenetskih dejavnikov,
will induce CYP3A4 and may
CYP3A4 in lahko zmanjšajo
Wilson’s disease is a rare inherited disorder where patients lack an enzyme that is needed to eliminate the copper contained in food from the body.
Wilsonova bolezen je redka prirojena napaka, pri kateri bolniki nimajo encima, potrebnega za izločanje bakra, ki se nahaja v hrani, iz telesa.
Wilson’s disease will persist during the entire lifetime of the patient and therefore the need for this treatment is life-long.
Wilsonova bolezen traja vse bolnikovo življenje, zato je tudi zdravljenje potrebno vse življenje.
Wilzin 50 mg hard capsules contains sunset yellow FCF (E110) which may cause allergic reactions.
Wilzin 50 mg trde kapsule vsebujejo sončno rumeno FCF (E110), ki lahko povzroča alergijske reakcije.
Wilzin is indicated in the treatment of Wilson’s disease, which is a rare inherited defect in copper excretion.
Wilzin se uporablja za zdravljenje Wilsonove bolezni, ki je redka dedna napaka v izločanju bakra.
Wilzin is used to treat Wilson’s disease.
Zdravilo Wilzin je namenjeno za zdravljenje Wilsonove bolezni.
Wilzin is usually not recommended for initial therapy of patients with signs and symptoms of Wilson’s disease because of its slow onset of action.
Navadno Wilzina ne priporočajo za začetno zdravljenje bolnikov z znaki in simptomi Wilsonove bolezni zaradi njegovega počasnega nastopa delovanja.
Wilzin should be taken on an empty stomach, separated from mealtimes.
Wilzin morate jemati na prazen želodec, ločeno od obrokov.
Wilzin treatment should be initiated under the supervision of a physician experienced in the treatment of Wilson’s disease (see section 4.4).
Zdravljenje z Wilzinom se mora uvesti pod nadzorom zdravnika, ki je izkušen v zdravljenju Wilsonove bolezni (glejte poglavje 4.4).
Wilzin treatment should be started by a doctor who has experience in the treatment of Wilson’s disease.
Zdravljenje z zdravilom Wilzin mora uvesti zdravnik z izkušnjami z zdravljenjem Wilsonove bolezni.
Wilzin zinc
Wilzin cink
Wim de Korverstraat 35, Boxmeer The Netherlands
Wim de Korverstraat 35, Boxmeer Nizozemska
Wim de Korverstraat 35, Boxmeer The Netherlands
Wim de Körverstraat 35, Boxmeer Nizozemska
Wim de Körverstraat 35 5831 AN Boxmeer The Netherlands
Wim de Körverstraat 35 5831 AN Boxmeer Nizozemska
Wim de Körverstraat 35 NL - 5831 AN Boxmeer The Netherlands
Intervet International B.V. Wim de Körverstraat 35 NL - 5831 AN Boxmeer Nizozemska
Wim de Körverstraat 35 NL - 5831 AN Boxmeer The Netherlands
Wim de Körverstraat 35 NL - 5831 AN Boxmeer Nizozemska
wind
vetrovi
Wind
vetrovi,
Wind (flatulence)
napenjanje (vetrovi)
wind (flatulence)
vetrovi (flatulenca)
wind (flatulence)
vetrovi (napenjanje)
wind (flatulence)
vetrovi (napenjanje),
wind (flatulence)
vetrovi (napihnjenost)
wind (flatulence)
vetrovi,
Wind (flatulence), with or without oily spotting
vetrovi (napenjanje) z ali brez oljnih madežev
Wind (flatulence), with or without oily spotting.
vetrovi (napenjanje) z ali brez oljnih madežev
Wind.
napenjanje,
Window
Okence
window
okence.
Window
prikaz
window (See Figure N).
kljukice (glejte sliko N).
Wingates Industrial Estate Westhoughton, Bolton Lancashire BL5 3XX United Kingdom
Wingates Industrial Estate Westhoughton, Bolton Lancashire BL5 3XX Združeno kraljestvo
Wingates Industrial Park Westhoughton, Bolton Lancashire BL5 3XX United Kingdom
Wingates Industrial Park Westhoughton, Bolton Lancashire BL5 3XX Velika Britanija
Wingates Industrial Park Westhoughton, Bolton Lancashire, BL5 3XX United Kingdom
Wingates Industrial Park Westhoughton, Bolton Lancashire BL5 3XX Velika Britanija
Wipe each vial top with a fresh alcohol pad.
Obrišite zgornjo površino vsake viale z novim alkoholnim zložencem.
Wipe off the venous port of the hemodialysis as instructed by your healthcare provider
istite venski dostop pri hemodializni krvni liniji, kot vam je naro il zdravstveni delavec.
Wipe only the TOP and OUTSIDE surfaces of the Base.
Obrišite samo ZGORNJO in ZUNANJE površine podnožja.
Wipe the chosen area with an alcohol swab.
trebuh, sprednjo stran stegna).
Wipe the injection site in a circular motion with the alcohol pad.
Mesto injiciranja obrišite z alkoholnim zložencem s krožnimi gibi.
Wipe the injection site on the skin with an antiseptic wipe
Z antiseptičnim zložencem obrišite predel kože, kamor boste injicirali zdravilo.
Wipe the injection site with a new alcohol swab.
Mesto injiciranja obrišite z novim alkoholnim tamponom.
Wipe the injection site with an alcohol swab.
Obrišite mesto injiciranja z alkoholnim zložencem.
Wipe the injection site with the alcohol pad, if necessary.
Obrišite mesto injiciranja z alkoholnim zložencem, če je potrebno.
Wipe the injection site with the enclosed alcohol pad, using a circular motion.
S krožnim gibom obrišite injekcijsko mesto s priloženim alkoholnim zložencem.
Wipe the injection site with the enclosed alcohol wipe, using a circular motion moving from the inside out.
Mesto za injiciranje obrišite s priloženim alkoholnim zložencem, s krožnim gibom navzven.
Wipe the nozzle and inside of the cap with a clean, dry tissue – see pictures i and j.
Obrišite nastavek in notranjost pokrovčka s čisto, suho krpico – glejte sliki i in j.
Wipe the nozzle and inside of the cap with a clean, dry tissue – see pictures i and j.
Obrišite šobo in notranjost pokrovčka s čisto, mehko krpico – glejte sliki i in j.
Wipe the outside of the FORSTEO with a damp cloth.
Zunanjost injekcijskega peresnika FORSTEO obrišite z vlažno krpo.
Wipe the outside of the syringe with a clean tissue.
Zunanjost brizge obrišite s čisto krpo.
Wipe the outside of the syringe with a clean tissue.
Zunanjost injekcijske brizge obrišite s čistim robčkom.
Wipe the rubber seal with a swab.
Gumijasto zaporko obrišite z zložencem.
Wipe the Rubber Seal with an alcohol swab.
Gumijasto zaporko obrišite z alkoholnim zložencem.
Wipe the rubber stopper and metal ring with your first alcohol swab.
Gumijasti zamašek in kovinski obroček obrišite s prvo alkoholno blazinico.
Wipe the rubber stopper on the vial with a sterile alcohol swab and allow it to air dry for a few seconds before use.
Obrišite gumijasti zamašek viale s sterilnim alkoholnim lističem in počakajte nekaj sekund, da se posuši, preden vialo uporabite.
Wipe the rubber stopper with an alcohol swab (not supplied) and allow it to dry prior to use.
Gumijasti zamašek obrišite z alkoholno krpico (ni priložena) in počakajte, da se osuši.
Wipe the site where Enbrel is to be injected with a new alcohol swab, using a circular motion.
Mesto, kjer nameravate vbrizgati zdravilo Enbrel, s krožnim gibom obrišite z alkoholno blazinico.
Wipe the site where Enbrel is to be injected with an alcohol swab, using a circular motion.
Mesto, kjer nameravate vbrizgati zdravilo Enbrel, s krožnim gibom obrišite z alkoholno blazinico.
Wipe the site where Nplate is to be injected with an alcohol swab, using a circular motion.
Z novim alkoholnim zložencem s krožnim gibom obrišite mesto, kamor boste injicirali zdravilo Nplate.
Wipe the top of the pre-filled pen where the needle is going to be attached with an alcohol swab (see Figure 4).
Vrhnji del napolnjenega injekcijskega peresnika, kamor pride igla, obrišite z alkoholnim tamponom (glejte sliko 4).
Wipe the top of the vial of the reconstituted suspension with a sterile alcohol swab.
Vrhnji del viale z rekonstituirano suspenzijo obrišemo s sterilno alkoholno blazinico.
Wipe the top of the vial with an alcohol swab.
Vrh viale obrišite z alkoholno blazinico.
Wipe the vial’s rubber stopper with an alcohol swab and place it on your flat work surface.
Obrišite gumijasti zamašek viale z alkoholnim zložencem in položite vialo na ravno delovno površino.
Wipe the wound surface gently before placing TachoSil on the wound.
Preden zdravilo TachoSil namestite na rano morate rano nežno obrisati.
Wipe your injection site with an alcohol swab in a circular motion.
S krožnim gibom obrišite mesto injiciranja z alkoholnim zložencem.
Wipe your skin with an alcohol swab, and let the injection site dry before you inject your dose.
Obrišite si kožo z alkoholnim zložencem in pustite, da se koža posuši, preden si vbrizgate odmerek.
Wipe your skin with an alcohol swab, and let your skin dry before you inject your dose.
Obrišite si kožo z alkoholnim zložencem in pustite, da se koža posuši, preden si vbrizgate odmerek.
wirl the product vial with the transparent adapter attached until the substance is fully dissolved.
Vialo z zdravilom s prozornim adapterjem nežno obračajte dokler se prašek popolnoma ne raztopi.
with
zdravilo z
with 3 pen needles
3 pakiranja s 3 iglami
with 3 pen needles
s 3 iglami za peresnik
with 3 pen needles
uporaba
with 3 pen needles
za peresnik
with a butyl
iz stekla
With a calculated adverse experience rate (per number of administrations) of 0,005% the frequency of these ADRs can be classified as very rare.
Ker je izračunana pogostnost neželenih pojavov (na število dajanj zdravila) znašala 0,005%, lahko te neželene učinke po pogostnosti uvrstimo med zelo redke.
With a cleansing swab, disinfect the rubber membrane of the cartridge.
Gumijasto membrano vložka razkužite z blazinico za čiščenje.
with a clinically
klinično pomembnim
with a history suggestive of torsades de pointes ventricular tachycardia (abnormal heart rhythms);
z anamnezo, ki kaže na ventrikularno tahikardijo tipa torsades de pointes (nenormalen srčni ritem);
With a loading dose of 300 mg or 600 mg clopidogrel, dabigatran AUCτ,ss and Cmax,ss were increased by about 30-40 % (see section 4.4) (see also subsection on ASA below).
Pri polnitvenem odmerku klopidogrela po 300 ali 600 mg sta se dabigatranovi AUCτ,ss in Cmax,ss povečali za približno 30 do 40 % (glejte poglavje 4.4) (glejte tudi podpoglavje ASK spodaj).
With a loading dose of 300 mg or 600 mg clopidogrel, dabigatran AUCτ,ss and Cmax,ss were increased by about 30-40 % (see section 4.4).
Pri polnitvenem odmerku klopidogrela po 300 ali 600 mg sta se dabigatranovi AUCτ,ss in Cmax,ss povečali za približno 30 do 40 % (glejte poglavje 4.4).
with a long history of diabetes,
imajo sladkorno bolezen že dolgo časa,
with a long history of diabetes,
z dolgo anamnezo diabetesa,
with a long history of diabetes,
z dolgo anamnezo sladkorne bolezni,
with a low dose ritonavir, it should
odmerkom ritonavirja in z
with a low dose ritonavir, it should
ritonavirja uporabljati sočasno s
With a median duration of follow-up of 40 months, median OS (56.3 months in the R-CHOP group, and not reached in the BR-CAP group) favoured the BR-CAP group, (estimated HR=0.80; p=0.173).
Med nadaljnjim spremljanjem bolnikov, ki je mediano trajalo 40 mesecev, je bila glede medianega OS (56,3 mesecev v skupini R-CHOP, v skupini BzR-CAP ni bilo doseženo) v prednosti skupina BzR-CAP (ocenjeno HR=0,80; p=0,173).
With a median duration of follow-up of 40 months, median OS (56.3 months in the R-CHOP group, and not reached in the BzR-CAP group) favoured the BzR-CAP group, (estimated HR=0.80; p=0.173).
Med nadaljnjim spremljanjem bolnikov, ki je mediano trajalo 40 mesecev, je bila glede medianega OS (56,3 mesecev v skupini R-CHOP, v skupini BzR-CAP ni bilo doseženo) v prednosti skupina BzR-CAP (ocenjeno HR=0,80; p=0,173).
With a median duration of follow-up of 40 months, median OS (56.3 months in the R-CHOP group, and not reached in the VcR-CAP group) favoured the VcR-CAP group, (estimated HR=0.80; p=0.173).
Med nadaljnjim spremljanjem bolnikov, ki je mediano trajalo 40 mesecev, je bila glede medianega OS (56,3 mesecev v skupini R-CHOP, v skupini VcR-CAP ni bilo doseženo) v prednosti skupina VcR-CAP (ocenjeno HR = 0,80; p = 0,173).
With a median observation time of 24.1 months for follicular lymphoma patients, 48 patients (28.1%) in the B arm and 30 patients (18.3%) in the G+B arm had died.
Mediani čas opazovanja za bolnike s folikularnim limfomom je bil 24,1 meseca; 48 bolnikov (28,1 %) iz skupine, ki je prejemala bendamustin, in 30 bolnikov (18,3 %) iz skupine, ki je prejemala G + B, je umrlo.
With a minimum of 24 months following the last patient’s first visit, and median treatment duration of
Po najmanj 24 mesecih po prvem obisku zadnjega bolnika in mediani trajanja zdravljenja
with a propensity to bleed (e.g. due to recent trauma, recent surgery, recent or recurrent gastrointestinal bleeding, or active peptic ulcer disease) with body weight < 60 kg (see sections 4.2 and 4.8).
z nagnjenostjo za krvavitev (npr. zaradi nedavne poškodbe, nedavnega kirurškega posega, nedavne ali ponovljene gastrointestinalne krvavitve ali aktivni peptični ulkus). s telesno maso < 60 kg (glejte poglavji 4.2 in 4.8).
With a quick, short motion, push the needle all the way into the skin at an angle between 45° and 90° (see Diagram 10).
S hitrim in kratkim gibom potisnite iglo do konca v kožo pod kotom 45 do 90 stopinj (glejte sliko 10).
With a quick, short motion, push the needle all the way into the skin at an angle between 45° and 90° (see Diagram 13).
S hitrim in kratkim gibom potisnite iglo do konca v kožo pod kotom 45 do 90 stopinj (glejte sliko 13).
With a quick, short motion, push the needle all the way into the skin at an angle between 45° and 90° (see Diagram 18).
S hitrim in kratkim gibom potisnite iglo do konca v kožo pod kotom 45 do 90 stopinj (glejte sliko 18).
With a quick, short motion, push the needle all the way into the skin at an angle between 45° and 90° (see Diagram10).
S hitrim in kratkim gibom potisnite iglo do konca v kožo pod kotom 45 do 90 stopinj (glejte sliko 10).
With a short, sharp motion, push the needle into the skin.
S kratkim, odločnim gibom iglo zabodite v kožo.
With a significantly higher conversion rate in patients treated with BRINAVESS, the incidence of bradycardia events was higher within the first 2 hours in vernakalant treated patients than in placebo-treated patients (5.4% versus 3.8%, respectively).
Zaradi pomembno večjega deleža konverzij med bolniki, zdravljenimi z zdravilom BRINAVESS, je bila pojavnost dogodkov bradikardije v prvih 2 urah večja pri bolnikih, ki so prejeli vernakalant (5,4 %), kot med tistimi, ki so prejeli placebo (3,8 %).
With a slow elimination rate (mean half life = 14 h, mean total body clearance, CL/F, = 84 ml/h/kg), renal clearance is negligible (5% of total body clearance), assuming 100% bioavailability.
Z majhno hitrostjo izločanja (povprečni razpolovni čas = 14 ur), povprečni celotni telesni očistek, CL/F = 84 ml/h/kg) je ledvični očistek zanemarljiv (5 % celotnega telesnega očistka), če predpostavimo 100-odstotno biološko uporabnost.
with a tumour near the fracture;
osebe s tumorjem v bližini mesta zloma;
with abacavir.
očasno z abakavirjem.
with active bleeding and/or irreversible coagulation disorders
z aktivno krvavitvijo in/ali ireverzibilnimi motnjami koagulacije,
With administration of Naglazyme it is recommended that patients be administered pre-treatment medicinal products (antihistamines with or without antipyretics) approximately 30-60 minutes prior to the start of the infusion, to minimise the potential occurrence of IARs.
Ob aplikaciji Naglazyma je približno 30 – 60 minut pred pričetkom infuzije za zmanjšanje tveganja za razvoj IAR priporočljiva premedikacija bolnikov (antihistaminiki z ali brez antipiretikov).
with aluminium and/or magnesium containing antacids is not recommended.
zdravila ISENTRESS z antacidi, ki vsebujejo aluminij in/ali magnezij, ni priporočljiva.
with an active infection at the surgery site or another serious infection;
osebe z aktivno okužbo na območju kirurškega posega ali drugo resno okužbo;
with an autoimmune disease (where the immune system attacks parts of the body);
osebe z avtoimunsko boleznijo (pri katerih imunski sistem napada dele telesa);
with an automatic safety
samodejnim varnostnim
with and
ali brez
With any baseline NS5A RAVs
S katerim koli izhodiščnim RAV NS5A
With appropriate clinical monitoring, individual patients may benefit from doses above 300 mg/m2/day.
Pri ustreznem kliničnem spremljanju lahko odmerki nad 300 mg/m2/dan ugodno vplivajo na posamezne bolnike.
with Aptivus, co-administered with
Sočasnega jemanja z zdravilom Aptivus ob hkratnih majhnih odmerkih ritonavirja ne priporočamo.
with astemizole or
karbamazepin
with atazanavir/ritonavir is not
atazanavirja/ritonavirja ne
with atorvastatin, fluvastatin,
očasno z atorvastatinom,
With baseline HIV-RNA
z začetno HIV- RNK
With Bazett’s correction (QTcB interval), the upper bound of one-sided 95% confidence interval (CI) for predicted effect on QTcB at Cmax was 5.9 msec.
Zgornja meja enostranskega 95 % intervala zaupanja (IZ) z Bazett-ovo korekcijo (QTcB interval) za predviden učinek na QTcB pri Cmax je bila 5,9 milisekund.
with boosted PREZISTA it may cause a
midazolama in okrepljenega zdravila
with boosted PREZISTA.
antipsihotikov.
With both schedules, primary immunisation should be completed at least one week prior to potential exposure to Japanese encephalitis virus (JEV) (see section 4.4).
Pri obeh urnikih je treba primarno cepljenje dopolniti vsaj en teden pred morebitno izpostavljenostjo virusu japonskega encefalitisa (JEV) (glejte poglavje 4.4).
with cancer in your ovaries, womb or breasts. with a condition that usually makes normal pregnancy impossible, such as ovarian failure (early menopause), or malformed reproductive organs.
z rakom jajčnika, maternice ali dojke; s stanjem, ki običajno onemogoča normalno nosečnost, kot je odpoved jajčnikov (prezgodnja menopavza) ali malformacijo spolnih organov;
with cancer in your ovaries, womb or breasts. with a condition that usually makes normal pregnancy impossible, such as ovarian failure (early menopause), or malformed reproductive organs.
z rakom jajčnika, maternice ali dojke; z boleznijo, ki običajno onemogoča normalno nosečnost, kot je odpoved jajčnikov (prezgodnja menopavza) ali malformacijo spolnih organov.
With cardiac disease
z boleznimi srca,
with caution and a lower
uporablja previdno, v
with caution at reduced doses of no
previdno v zmanjšanih odmerkih, ki
with caution due to possible cardiac
možnega pojava srčne aritmije ga
with caution when
pričakovano.
with caution.
potrebna previdnost.
With certain other risk factors listed in the product information
Z nekaterimi drugimi dejavniki tveganja, navedenimi v informacijah o zdravilu
With cessation of treatment, blood pressure gradually returned towards baseline levels over a period of several weeks, with no evidence of a rebound effect for blood pressure or PRA.
Po prenehanju zdravljenja se je krvni tlak v obdobju nekaj tednov postopoma vrnil na izhodiščne vrednosti, pri tem ni bilo nobenih znakov za povratni učinek niti glede krvnega tlaka niti glede aktivnosti renina v plazmi.
with chest pain due to heart disease (acute coronary syndromes - ACS) who are having surgery to treat blockages in their blood vessels (angioplasty and/or percutaneous coronary intervention - PCI).
z bolečinami v prsih zaradi srčne bolezni (akutni koronarni sindrom – AKS) ki imajo kirurški poseg za zdravljenje blokad v žilah (angioplastika ali perkutana koronarna intervencija – PCI ali oboje).
With cholestatic hepatitis
holestatičnim hepatitisom,